WallStreetZenWallStreetZen

NYSE: NVS
Novartis Ag Stock

Overview
ForecastEarningsRevenueDividendOwnership
$113.45+0.82 (+0.73%)
Updated Apr 29, 2025
NVS Price
$113.45
Fair Value Price
N/A
Market Cap
$222.28B
52 Week Low
$96.06
52 Week High
$120.92
P/E
17.62x
P/B
5.79x
P/S
4.12x
PEG
1.38x
Dividend Yield
3.41%
Revenue
$53.22B
Earnings
$12.86B
Gross Margin
75.7%
Operating Margin
30.01%
Profit Margin
24.2%
Debt to Equity
1.6
Operating Cash Flow
$19B
Beta
0.36
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

NVS Overview

Novartis AG manufactures prescription medications related to oncology, ophthalmology, neuroscience, immunology, respiratory, and cardio-metabolic medicine. Novartis AG is collaborating with Alnylam Pharmaceuticals to commercialize inclisiran. The company is also collaborating with Kura Oncology, Inc. to evaluate the combination of Tipifarnib and Alpelisib in patients with head and neck squamous cell carcinoma. Novartis AG was incorporated in 1996 and is headquartered in Basel, Switzerland.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine NVS's potential to beat the market

AStrong Buy
  • Stocks with a Zen Rating of Strong Buy (A) had an average return of +32.52% per year. Learn More
View All “A” Zen Rated Stocks
→

Zen Rating Component Grades

B
Value
C
Growth
C
Momentum
B
Sentiment
B
Safety
B
Financials
B
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: General Drug Manufacturer

Industry Rating
A
NVS
Ranked#1 of 18

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
Astrazeneca (AZN)
$71.71A
Johnson & Johnson (JNJ)
$155.91A
Gilead Sciences (GILD)
$104.21A
View Top General Drug Manufacturer Stocks

Be the first to know about important NVS news, forecast changes, insider trades & much more!

NVS News

Overview

Due Diligence Score

–
Industry Average (40)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how NVS scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

NVS ($113.45) is trading above its intrinsic value of $65.34, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
NVS is good value based on its earnings relative to its share price (17.62x), compared to the US market average (29.19x)
P/E vs Market Valuation
NVS is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more NVS due diligence checks available for Premium users.

Valuation

NVS price to earnings (PE)

For valuing profitable companies with steady earnings

Company
17.62x
Industry
54.14x
Market
29.19x
NVS is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
NVS is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

NVS price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
5.79x
Industry
6.28x
NVS is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

NVS price to earnings growth (PEG)

For valuing profitable companies with growth potential

NVS is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

NVS's financial health

Profit margin

Revenue
$13.6B
Net Income
$3.6B
Profit Margin
26.5%
NVS's Earnings (EBIT) of $15.97B... subscribe to Premium to read more.
Interest Coverage Financials
NVS's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$99.9B
Liabilities
$61.5B
Debt to equity
1.6
NVS's short-term liabilities ($31.62B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
NVS's long-term liabilities ($29.87B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
NVS's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
NVS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$3.6B
Investing
$330.0M
Financing
-$8.5B
NVS's operating cash flow ($19.00B)... subscribe to Premium to read more.
Debt Coverage Financials

NVS vs General Drug Manufacturer Stocks

TickerZen RatingMarket Cap1d %P/EP/B
NVSA$222.28B+0.73%17.62x5.79x
AZNA$222.30B+2.55%28.63x5.42x
MRKC$213.98B+1.83%12.53x4.62x
AMGNC$155.02B+1.93%37.87x26.38x
SNYC$135.71B+1.82%23.23x1.68x
View Top General Drug Manufacturer Stocks

Novartis Ag Stock FAQ

What is Novartis Ag's quote symbol?

(NYSE: NVS) Novartis Ag trades on the NYSE under the ticker symbol NVS. Novartis Ag stock quotes can also be displayed as NYSE: NVS.

If you're new to stock investing, here's how to buy Novartis Ag stock.

What is the 52 week high and low for Novartis Ag (NYSE: NVS)?

(NYSE: NVS) Novartis Ag's 52-week high was $120.92, and its 52-week low was $96.06. It is currently -6.18% from its 52-week high and 18.1% from its 52-week low.

How much is Novartis Ag stock worth today?

(NYSE: NVS) Novartis Ag currently has 1,959,300,000 outstanding shares. With Novartis Ag stock trading at $113.45 per share, the total value of Novartis Ag stock (market capitalization) is $222.28B.

Novartis Ag stock was originally listed at a price of $40.69 in Dec 31, 1997. If you had invested in Novartis Ag stock at $40.69, your return over the last 27 years would have been 178.85%, for an annualized return of 3.87% (not including any dividends or dividend reinvestments).

How much is Novartis Ag's stock price per share?

(NYSE: NVS) Novartis Ag stock price per share is $113.45 today (as of Apr 29, 2025).

What is Novartis Ag's Market Cap?

(NYSE: NVS) Novartis Ag's market cap is $222.28B, as of Apr 30, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Novartis Ag's market cap is calculated by multiplying NVS's current stock price of $113.45 by NVS's total outstanding shares of 1,959,300,000.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.